Dato for offentliggørelse af delårsrapport for første halvår (Q2) 2023 for ALK og webcast
August 18, 2023 06:45 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF) offentliggør delårsrapport for første halvår (Q2) 2023 torsdag den 24. august 2023. ALK afholder samme dag kl. 13.30 (CEST) en telefonkonference for investorer og...
Administrerende direktør Carsten Hellmann fratræder ved udgangen af 2023. Peter Halling udpeget som hans efterfølger
June 19, 2023 02:40 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF) meddeler i dag, at Carsten Hellmann fratræder som administrerende direktør ved udgangen af 2023. Han efterfølges af Peter Halling senest den 1. januar 2024. ...
President & CEO Carsten Hellmann to step down end 2023. Peter Halling appointed as his successor
June 19, 2023 02:40 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that Carsten Hellman will step down as President & CEO at the end of 2023. He will be succeed by Peter Halling no later than 1 January 2024. The...
Stort, succesfuldt klinisk fase 3-studie når sit primære endemål og bekræfter potentialet af ALK's tabletvaccine mod husstøvmideallergi hos børn
June 08, 2023 10:27 ET
|
ALK Abello
Studiet mødte sit primære og alle væsentlige sekundære endemål med en forbedring i den totale kombinerede allergiske rhinitis-score (TCRS) på 22 % sammenlignet med placebo (primært endemål)....
Large Phase 3 clinical trial successfully meets primary endpoint, confirming the potential of ALK’s house dust mite tablet in young children
June 08, 2023 10:27 ET
|
ALK Abello
Primary and all key secondary confirmatory endpoints were met, with an improvement in the total combined allergic rhinitis score (TCRS) of 22% compared to placebo (primary endpoint). Results were...
Three-month interim report (Q1) 2023
May 09, 2023 01:20 ET
|
ALK Abello
Bemærk venligst, at rapporten udelukkende forefindes på engelsk. Revenue up 7%, full-year outlook maintained (unaudited) ALK’s overall results in Q1 2023 were largely as expected, with 7% organic...
Three-month interim report (Q1) 2023
May 09, 2023 01:20 ET
|
ALK Abello
Revenue up 7%, full-year outlook maintained (unaudited) ALK’s overall results in Q1 2023 were largely as expected, with 7% organic revenue growth in local currencies and increased operating profit...
Dato for offentliggørelse af delårsrapport for første kvartal 2023 for ALK og webcast
May 01, 2023 04:18 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF) offentliggør delårsrapport for første kvartal 2023 tirsdag den 9. maj 2023. ALK afholder samme dag kl. 13.30 (CEST) en telefonkonference for investorer og...
Release date of three-month interim report (Q1) 2023 for ALK and audio cast
May 01, 2023 04:18 ET
|
ALK Abello
On Tuesday, 9 May 2023 ALK (ALKB:DC / OMX: ALK B / AKBLF) releases its three-month interim report (Q1) 2023. ALK will host a meeting for analysts and institutional investors that day at 1.30pm (CEST)...
ALK announces preliminary Q1 figures and confirms its full-year revenue and earnings outlook
April 17, 2023 12:15 ET
|
ALK Abello
ALK’s (ALKB:DC / OMX: ALK B / AKBLF) overall results in Q1 2023 were largely as expected with 7% organic revenue growth in local currencies and increasing operating profit (EBIT). Combined SCIT and...